Azitra Inc.
Clinical trials sponsored by Azitra Inc., explained in plain language.
-
First-of-its-Kind skin treatment trial offers hope for rare genetic disorder
Disease control Recruiting nowThis is the first time a new topical ointment called ATR12-351 is being tested in people. The study aims to see if it is safe and well-tolerated in about 12 adults with Netherton Syndrome, a rare and severe genetic skin condition. The ointment is designed to address the root caus…
Phase: PHASE1 • Sponsor: Azitra Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New gel tested to soothe painful rash from cancer drugs
Symptom relief Recruiting nowThis study is testing a new topical gel, ATR04-484, to see if it is safe and can help treat a severe, itchy skin rash that is a common side effect of certain cancer medications (EGFR inhibitors). Adult cancer patients with this moderate-to-severe rash will apply the gel or a plac…
Phase: PHASE1, PHASE2 • Sponsor: Azitra Inc. • Aim: Symptom relief
Last updated Feb 19, 2026 14:36 UTC